Premium
Oral pregabalin as an add‐on treatment for status epilepticus
Author(s) -
Novy Jan,
Rossetti Andrea O.
Publication year - 2010
Publication title -
epilepsia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.687
H-Index - 191
eISSN - 1528-1167
pISSN - 0013-9580
DOI - 10.1111/j.1528-1167.2010.02646.x
Subject(s) - pregabalin , status epilepticus , refractory (planetary science) , medicine , partial seizures , partial epilepsy , anesthesia , intensive care unit , epilepsy , antiepileptic drug , intensive care medicine , pediatrics , psychiatry , physics , astrobiology
Summary Oral antiepileptic drugs (AEDs) represent possible add‐on options in refractory status epilepticus (SE). In this setting, pregabalin (PGB) has not been reported before. Over the last 42 months, we identified 11 SE episodes (10 patients) treated with PGB in our hospital. Its use was prompted by the favorable pharmacokinetic profile, devoid of drug‐drug interactions. The patients mostly had refractory, partial SE. Only two patients were managed in the intensive care unit (ICU). We found a definite electroclinical response in 5 of 11, already evident 24 h after PGB introduction, and a possible response (concomitantly with other AEDs) in 3 of 11 of the episodes; 3/11 did not respond. The treatment was well tolerated. Partial SE appeared to better respond than generalized convulsive SE. PGB appears to be an interesting option as add‐on treatment in refractory partial SE.